Loading clinical trials...
Loading clinical trials...
Systemic Scleroderma (SCS) is an autoimmune disease characterized by vascular involvement, a dysimmune condition, cutaneous and visceral fibrosis. Interstitial lung disease (ILD) affects 75% of SSc pa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique Hopitaux De Marseille
NCT07343115 · Systemic Scleroderma
NCT07090226 · Systemic Scleroderma, Diffuse Cutaneous Scleroderma
NCT05726630 · Systemic Scleroderma
NCT07326033 · Systemic Scleroderma
NCT03816189 · Systemic Sclerosis, Systemic Scleroderma
Assistance Publique Hopitaux de Marseille
Marseille, BDR
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions